Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This case was reported by a physician in the frame of a PASS study and described the occurrence of intussusception in a 3-month-old female subject who was vaccinated with ROTARIX, (GlaxoSmithKline). Previous and/or concurrent vaccination included DTAP-IPV-HIB; manufacturer unspecified; intramuscular given on 13 October 2008; HEP B vaccine recombinant; manufacturer unspecified; intramuscular given on 13 October 2008. On 13 October 2008 the subject received 1st dose of ROTARIX (oral). On 15 October 2008, 2 days after vaccination with ROTARIX, the subject started with a pharyngeal infection, intolerance to oral feeding, gastrobiliary vomiting and current jelly stools. She received ambulatory treatment (not specified) without improvement. On 18 October 2008 the subject was hospitalized. Physical examination reported abdominal pain, abdominal distention, gastrobiliar vomiting and irritability. The abdominal x-ray showed air-fluid levels. The same day the subject underwent a surgery. Ileoileal intussusception was found and it was reduced by taxis without improvement. A ileal resection was performed (length 20 cm and termino-terminal anastomosis with good evolution). On 28 October the subject was discharged in good conditions. The subject was treated with omeprazole, metronadizole, cefotaxime, amikacin, METAMIZOL, KETOROLAC, and ALBUMINE. The physician considered the events were possibly related to vaccination with ROTARIX.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166